Author:
Mier James W.,Vachino Gloria,van der Meer Jos W. M.,Numerof Robert P.,Adams Sharlene,Cannon Joseph G.,Bernheim Harry A.,Atkins Michael B.,Parkinson David R.,Dinarello Charles A.
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference33 articles.
1. Lotze M, Matory Y, Ettinghausen S, Raynor A, Sharrow S, Siepp C, Custer M, Rosenberg S:In vivo administration of purified human Interleukin-2. II. Half-life, immunologic effects, and expansion of peripheral lymphoid cellsin vivo with recombinant IL-2. J Immunol 135:2865?2870, 1985
2. Atkins MB, Gould JA, Allegretta M, Li JJ, Dempsey RA, Rudders RA, Parkinson DR, Reichlin S, Mier JW: Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease. J Clin Oncol 4:1380?1391, 1986
3. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Siepp CA, Simpson C, Reichart CM: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313:1485?1492, 1985
4. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316:889?897, 1987
5. West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Oldham RK: Constant infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 316:898?905, 1987
Cited by
197 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献